COMP <GO>
GRDN vs KO // FREE CASH FLOW YIELD
Guardian Pharmacy Services Inc. (Class A) (NYSE) VS. Coca-Cola Company (NYSE) • 15-METRIC TALLY: GRDN 4
— KO 8
▲ FREE CASH FLOW YIELD LEADER: GRDN
LAST: $40.45 (+0.30%) • MKT CAP: $2.56B
fcf-yield
3.91%
LAST: $92.82 (+1.19%) • MKT CAP: $399.30B
fcf-yield
1.33%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (GRDN VS. KO)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | GRDN | KO | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 20.20% | 61.60% | -41.40 | KO | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 37.70% | 25.30% | +12.40 | GRDN | /roic <GO> |
| EV/EBITDA & P/E Valuation | 34.3x | 26.4x | +7.90 | KO | /valuation <GO> |
| Free Cash Flow Yield ACTIVE | 3.91% | 1.33% | +2.58 | GRDN | /fcf-yield <GO> |
| Operating Margin | 5.00% | 28.70% | -23.70 | KO | /operating-margins <GO> |
| Net Profit Margin | 3.40% | 27.30% | -23.90 | KO | /net-margins <GO> |
| Revenue Growth (YoY) | 17.90% | 1.90% | +16.00 | GRDN | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.20% | -2.20 | KO | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 12.39 | 6.84 | +5.55 | GRDN | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | — | — | — | TIE | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 49.3 | 56.8 | -7.50 | KO | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | — | 0.92 | — | TIE | /macro-sensitivity <GO> |
| Forward P/E Multiple | 43.8x | 28.4x | +15.40 | KO | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $2.56B | $399.30B | -$396.74B | KO | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | GRDN REV | KO REV | GRDN GROSS % | KO GROSS % | GRDN FCF | KO FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.45B | $47.94B | 20.2% | 61.6% | $100.3M | $5.30B |
| FY 2024 | $1.23B | $47.06B | 19.9% | 61.1% | $58.0M | $4.74B |
| FY 2023 | — | $45.75B | — | — | — | $9.54B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
GRDN // BETA —
KO // BETA 0.92